{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:21:37Z","timestamp":1791145297001,"version":"4.1.0"},"reference-count":40,"publisher":"American Association for Cancer Research (AACR)","issue":"10","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Xeroderma pigmentosum group C (XPC) is an important DNA damage recognition protein that binds to damaged DNA at a very early stage during DNA repair. The XPC protein is also involved in DNA damage\u2013induced cell cycle checkpoint regulation and apoptosis. XPC defects are associated with many types of solid tumors. The mechanism of the XPC protein in cancer progression, however, remains unclear. In this report, we showed the strong correlation between bladder cancer progression and attenuated XPC protein expression using tissues derived from patients with bladder cancer. The results obtained from our immunohistochemical studies further revealed a strong correlation of XPC deficiency, p53 mutation, and the degree of malignancy of bladder tumors. In addition, the results obtained from our studies have also shown that HT1197 bladder cancer cells, which carry a low-level XPC protein, exhibited a decreased DNA repair capability and were resistant to cisplatin treatment. When an XPC gene cDNA-expression vector was stably transfected into the HT1197 cells, however, the cisplatin treatment\u2013induced apoptotic cell death was increased. Increased p53 and p73 responses following cisplatin treatment were also observed in HT1197 cells stably transfected with XPC cDNA. Taken together, these results suggest that XPC deficiency is an important contributing factor in bladder tumor progression and bladder cancer cell drug resistance. [Cancer Res 2007;67(10):4578\u201385]<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-0877","type":"journal-article","created":{"date-parts":[[2007,5,18]],"date-time":"2007-05-18T07:12:30Z","timestamp":1179472350000},"page":"4578-4585","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Attenuated Expression of Xeroderma Pigmentosum Group C Is Associated with Critical Events in Human Bladder Cancer Carcinogenesis and Progression"],"prefix":"10.1158","volume":"67","author":[{"given":"Zhiwen","family":"Chen","sequence":"first","affiliation":[{"name":"1Urology Institute of People's Liberation Army, Southwest Hospital, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Yang","sequence":"additional","affiliation":[{"name":"2Department of Biochemistry and Molecular Biology, The Third Military Medical University, Chongqing, P.R. China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gan","family":"Wang","sequence":"additional","affiliation":[{"name":"3Institute of Environmental Health Sciences, Wayne State University, Detroit, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Song","sequence":"additional","affiliation":[{"name":"1Urology Institute of People's Liberation Army, Southwest Hospital, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[{"name":"1Urology Institute of People's Liberation Army, Southwest Hospital, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Xu","sequence":"additional","affiliation":[{"name":"1Urology Institute of People's Liberation Army, Southwest Hospital, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,5,17]]},"reference":[{"key":"2022061623205927700_B1","doi-asserted-by":"crossref","unstructured":"Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin\u20082005; 55: 10\u201330.","DOI":"10.3322\/canjclin.55.1.10"},{"key":"2022061623205927700_B2","doi-asserted-by":"crossref","unstructured":"van der Spek PJ, Eker A, Rademakers S, et al. XPC and human homologs of RAD23: intracellular localization and relationship to other nucleotide excision repair complexes. Nucleic Acids Res\u20081996; 24: 2551\u20139.","DOI":"10.1093\/nar\/24.13.2551"},{"key":"2022061623205927700_B3","doi-asserted-by":"crossref","unstructured":"Li L, Lu X, Peterson C, Legerski R. XPC interacts with both HHR23B and HHR23A in vivo. Mutat Res\u20081997; 383: 197\u2013203.","DOI":"10.1016\/S0921-8777(97)00002-5"},{"key":"2022061623205927700_B4","doi-asserted-by":"crossref","unstructured":"Sugasawa K, Ng JM, Masutani C, et al. Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol Cell\u20081998; 2: 223\u201332.","DOI":"10.1016\/S1097-2765(00)80132-X"},{"key":"2022061623205927700_B5","doi-asserted-by":"crossref","unstructured":"Yokoi M, Masutani C, Maekawa T, Sugasawa K, Ohkuma Y, Hanaoka F. The xeroderma pigmentosum group C protein complex XPC-HR23B plays an important role in the recruitment of transcription factor IIH to damaged DNA. J Biol Chem\u20082000; 275: 9870\u20135.","DOI":"10.1074\/jbc.275.13.9870"},{"key":"2022061623205927700_B6","doi-asserted-by":"crossref","unstructured":"Popescu A, Miron S, Blouquit Y, Duchambon P, Christova P, Craescu CT. Xeroderma pigmentosum group C protein possesses a high affinity binding site to human centrin 2 and calmodulin. J Biol Chem\u20082003; 278: 40252\u201361.","DOI":"10.1074\/jbc.M302546200"},{"key":"2022061623205927700_B7","doi-asserted-by":"crossref","unstructured":"Hey T, Lipps G, Sugasawa K, Iwai S, Hanaoka F, Krauss G. The XPC-HR23B complex displays high affinity and specificity for damaged DNA in a true-equilibrium fluorescence assay. Biochemistry\u20082002; 41: 6583\u20137.","DOI":"10.1021\/bi012202t"},{"key":"2022061623205927700_B8","doi-asserted-by":"crossref","unstructured":"Wood RD. DNA damage recognition during nucleotide excision repair in mammalian cells. Biochimie\u20081999; 81: 39\u201344.","DOI":"10.1016\/S0300-9084(99)80036-4"},{"key":"2022061623205927700_B9","doi-asserted-by":"crossref","unstructured":"Volker M, Mone MJ, Karmakar P, et al. Sequential assembly of the nucleotide excision repair factors in vivo. Mol Cell\u20082001; 8: 213\u201324.","DOI":"10.1016\/S1097-2765(01)00281-7"},{"key":"2022061623205927700_B10","doi-asserted-by":"crossref","unstructured":"Wang G, Chuang L, Zhang X, et al. The initiative role of XPC protein in cisplatin DNA damaging treatment-mediated cell cycle regulation. Nucleic Acids Res\u20082004; 32: 2231\u201340.","DOI":"10.1093\/nar\/gkh541"},{"key":"2022061623205927700_B11","doi-asserted-by":"crossref","unstructured":"Stout GJ, Oosten M, Acherrat FZ, et al. Selective DNA damage responses in murine Xpa(\u2212\/\u2212), Xpc(\u2212\/\u2212) and Csb(\u2212\/\u2212) keratinocyte cultures. DNA Repair (Amst)\u20082005; 4: 1337\u201344.","DOI":"10.1016\/j.dnarep.2005.07.012"},{"key":"2022061623205927700_B12","doi-asserted-by":"crossref","unstructured":"Hollander MC, Philburn RT, Patterson AD, et al. Deletion of XPC leads to lung tumors in mice and is associated with early events in human lung carcinogenesis. Proc Natl Acad Sci U S A\u20082005; 102: 13200\u20135.","DOI":"10.1073\/pnas.0503133102"},{"key":"2022061623205927700_B13","doi-asserted-by":"crossref","unstructured":"Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol\u20081987; 123: 241\u201350.","DOI":"10.1001\/archderm.123.2.241"},{"key":"2022061623205927700_B14","doi-asserted-by":"crossref","unstructured":"Tanaka K, Kamiuchi S, Ren Y, et al. UV-induced skin carcinogenesis in xeroderma pigmentosum group A (XPA) gene-knockout mice with nucleotide excision repair-deficiency. Mutat Res\u20082001; 477: 31\u201340.","DOI":"10.1016\/S0027-5107(01)00093-8"},{"key":"2022061623205927700_B15","doi-asserted-by":"crossref","unstructured":"Friedberg EC, Bond JP, Burns DK, et al. Defective nucleotide excision repair in xpc mutant mice and its association with cancer predisposition. Mutat Res\u20082000; 459: 99\u2013108.","DOI":"10.1016\/S0921-8777(99)00068-3"},{"key":"2022061623205927700_B16","doi-asserted-by":"crossref","unstructured":"Berg RJ, Ruven HJ, Sands AT, de Gruijl FR, Mullenders LH. Defective global genome repair in XPC mice is associated with skin cancer susceptibility but not with sensitivity to UVB induced erythema and edema. J Invest Dermatol\u20081998; 110: 405\u20139.","DOI":"10.1111\/j.1523-1747.1998.00173.x"},{"key":"2022061623205927700_B17","doi-asserted-by":"crossref","unstructured":"Nahari D, McDaniel LD, Task LB, Daniel RL, Velasco-Miguel S, Friedberg EC. Mutations in the Trp53 gene of UV-irradiated Xpc mutant mice suggest a novel Xpc-dependent DNA repair process. DNA Repair (Amst)\u20082004; 3: 379\u201386.","DOI":"10.1016\/j.dnarep.2003.03.001"},{"key":"2022061623205927700_B18","doi-asserted-by":"crossref","unstructured":"Matullo G, Guarrera S, Sacerdote C, et al. Polymorphisms\/haplotypes in DNA repair genes and smoking: a bladder cancer case-control study. Cancer Epidemiol Biomarkers Prev\u20082005; 14: 2569\u201378.","DOI":"10.1158\/1055-9965.EPI-05-0189"},{"key":"2022061623205927700_B19","doi-asserted-by":"crossref","unstructured":"Sanyal S, Festa F, Sakano S, et al. Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis\u20082004; 25: 729\u201334.","DOI":"10.1093\/carcin\/bgh058"},{"key":"2022061623205927700_B20","doi-asserted-by":"crossref","unstructured":"Shen M, Berndt SI, Rothman N, et al. Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China. Int J Cancer\u20082005; 116: 768\u201373.","DOI":"10.1002\/ijc.21117"},{"key":"2022061623205927700_B21","unstructured":"Shen H, Sturgis EM, Khan SG, et al. An intronic poly(AT) polymorphism of the DNA repair gene XPC and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Res\u20082001; 61: 3321\u20135."},{"key":"2022061623205927700_B22","doi-asserted-by":"crossref","unstructured":"Wang G, Chen Z, Zhang S, Wilson GL, Jing K. Detection and determination of oligonucleotide triplex formation-mediated transcription-coupled DNA repair in HeLa nuclear extracts. Nucleic Acids Res\u20082001; 29: 1801\u20137.","DOI":"10.1093\/nar\/29.8.1801"},{"key":"2022061623205927700_B23","doi-asserted-by":"crossref","unstructured":"Chen Z, Xu XS, Yang J, Wang G. Defining the function of XPC protein in psoralen and cisplatin-mediated DNA repair and mutagenesis. Carcinogenesis\u20082003; 24: 1111\u201321.","DOI":"10.1093\/carcin\/bgg051"},{"key":"2022061623205927700_B24","doi-asserted-by":"crossref","unstructured":"Bernardini S, Adessi GL, Billerey C, Chezy E, Carbillet JP, Bittard H. Immunohistochemical detection of p53 protein overexpression versus gene sequencing in urinary bladder carcinomas. J Urol\u20081999; 162: 1496\u2013501.","DOI":"10.1016\/S0022-5347(05)68347-4"},{"key":"2022061623205927700_B25","unstructured":"Esrig D, Spruck CH III, Nichols PW, et al. p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am J Pathol\u20081993; 143: 1389\u201397."},{"key":"2022061623205927700_B26","doi-asserted-by":"crossref","unstructured":"Gonzalez VM, Fuertes MA, Alonso C, Perez JM. Is cisplatin-induced cell death always produced by apoptosis? Mol Pharmacol\u20082001; 59: 657\u201363.","DOI":"10.1124\/mol.59.4.657"},{"key":"2022061623205927700_B27","doi-asserted-by":"crossref","unstructured":"Gong JG, Costanzo A, Yang HQ, et al. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature\u20081999; 399: 806\u20139.","DOI":"10.1038\/21690"},{"key":"2022061623205927700_B28","doi-asserted-by":"crossref","unstructured":"Bernstein C, Bernstein H, Payne CM, Garewal H. DNA repair\/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutat Res\u20082002; 511: 145\u201378.","DOI":"10.1016\/S1383-5742(02)00009-1"},{"key":"2022061623205927700_B29","doi-asserted-by":"crossref","unstructured":"Hoogervorst EM, van Oostrom CT, Beems RB, et al. 2-AAF\u2013induced tumor development in nucleotide excision repair-deficient mice is associated with a defect in global genome repair but not with transcription coupled repair. DNA Repair (Amst)\u20082005; 4: 3\u20139.","DOI":"10.1016\/j.dnarep.2004.08.009"},{"key":"2022061623205927700_B30","doi-asserted-by":"crossref","unstructured":"Fitch ME, Nakajima S, Yasui A, Ford JM. In vivo recruitment of XPC to UV-induced cyclobutane pyrimidine dimers by the DDB2 gene product. J Biol Chem\u20082003; 278: 46906\u201310.","DOI":"10.1074\/jbc.M307254200"},{"key":"2022061623205927700_B31","doi-asserted-by":"crossref","unstructured":"Adimoolam S, Ford JM. p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene. Proc Natl Acad Sci U S A\u20082002; 99: 12985\u201390.","DOI":"10.1073\/pnas.202485699"},{"key":"2022061623205927700_B32","doi-asserted-by":"crossref","unstructured":"Wang QE, Zhu Q, Wani MA, Wani G, Chen J, Wani AA. Tumor suppressor p53 dependent recruitment of nucleotide excision repair factors XPC and TFIIH to DNA damage. DNA Repair (Amst)\u20082003; 2: 483\u201399.","DOI":"10.1016\/S1568-7864(03)00002-8"},{"key":"2022061623205927700_B33","doi-asserted-by":"crossref","unstructured":"Catto JW, Meuth M, Hamdy FC. Genetic instability and transitional cell carcinoma of the bladder. BJU Int\u20082004; 93: 19\u201324.","DOI":"10.1111\/j.1464-410X.2004.04548.x"},{"key":"2022061623205927700_B34","unstructured":"Hoque MO, Lee CC, Cairns P, Schoenberg M, Sidransky D. Genome-wide genetic characterization of bladder cancer: a comparison of high-density single-nucleotide polymorphism arrays and PCR-based microsatellite analysis. Cancer Res\u20082003; 63: 2216\u201322."},{"key":"2022061623205927700_B35","unstructured":"Cordon-Cardo C, Reuter VE. Alterations of tumor suppressor genes in bladder cancer. Semin Diagn Pathol\u20081997; 14: 123\u201332."},{"key":"2022061623205927700_B36","doi-asserted-by":"crossref","unstructured":"Brandau S, Bohle A. Bladder cancer. I. Molecular and genetic basis of carcinogenesis. Eur Urol\u20082001; 39: 491\u20137.","DOI":"10.1159\/000052494"},{"key":"2022061623205927700_B37","doi-asserted-by":"crossref","unstructured":"Yang J, Chen Z, Liu Y, Hickey RJ, Malkas LH. Altered DNA polymerase iota expression in breast cancer cells leads to a reduction in DNA replication fidelity and a higher rate of mutagenesis. Cancer Res\u20082004; 64: 5597\u2013607.","DOI":"10.1158\/0008-5472.CAN-04-0603"},{"key":"2022061623205927700_B38","doi-asserted-by":"crossref","unstructured":"Wang QE, Zhu Q, Wani G, El-Mahdy MA, Li J, Wani AA. DNA repair factor XPC is modified by SUMO-1 and ubiquitin following UV irradiation. Nucleic Acids Res\u20082005; 33: 4023\u201334.","DOI":"10.1093\/nar\/gki684"},{"key":"2022061623205927700_B39","doi-asserted-by":"crossref","unstructured":"Cheng L, MacLennan GT, Zhang S, Wang M, Pan CX, Koch MO. Laser capture microdissection analysis reveals frequent allelic losses in papillary urothelial neoplasm of low malignant potential of the urinary bladder. Cancer\u20082004; 101: 183\u20138.","DOI":"10.1002\/cncr.20343"},{"key":"2022061623205927700_B40","unstructured":"Li M, Zhang ZF, Reuter VE, Cordon-Cardo C. Chromosome 3 allelic losses and microsatellite alterations in transitional cell carcinoma of the urinary bladder. Am J Pathol\u20081996; 149: 229\u201335."}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/10\/4578\/2569322\/4578.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/10\/4578\/2569322\/4578.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T02:44:42Z","timestamp":1655433882000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/10\/4578\/533106\/Attenuated-Expression-of-Xeroderma-Pigmentosum"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,15]]},"references-count":40,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2007,5,17]]},"published-print":{"date-parts":[[2007,5,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-0877","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,15]]}}}